Sensitive Detection of Gamma-H2AX Induction as a Pharmacodynamic Marker for Profiling Patients With Cancer Treated With Topotecan
Découvrez nos ressources
Types de ressources
Thèmes
-
Download Poster Sensitive Detection of Gamma-H2AX Induction as a Pharmacodynamic Marker for Profiling Patients With Cancer Treated With Topotecan
-
Download Poster Molecular Characterization of Circulating Tumor Cells Using a Highly Sensitive Method of Enrichment Based on the CellSearch CTC Profile Kit
Molecular Characterization of Circulating Tumor Cells Using a Highly Sensitive Method of Enrichment Based on the CellSearch CTC Profile Kit
-
Download Poster High Content Imaging and Characterization of Circulating Tumor Cells (CTC) from Cancer Patients
High Content Imaging and Characterization of Circulating Tumor Cells (CTC) from Cancer Patients
%20from%20Cancer%20Patients.jpg?width=270&height=350&name=103.%20High%20Content%20Imaging%20and%20Characterization%20of%20Circulating%20Tumor%20Cells%20(CTC)%20from%20Cancer%20Patients.jpg)
-
Download Case Study Biomarker Assay Validation for Intra-Tumoral Quantification of Phosphorylated VEGFR-2
Biomarker Assay Validation for Intra-Tumoral Quantification of Phosphorylated VEGFR-2
-
Download Poster BRAF V600E Mutation Allele- Specific PCR Assay in Circulating Tumor Cells
BRAF V600E Mutation Allele- Specific PCR Assay in Circulating Tumor Cells
-
Download Poster AACR 2020 Poster: QuANTUM-R Biomarker Encore Poster
AACR 2020 Poster: QuANTUM-R Biomarker Encore Poster
-
Download Poster pKDR/KDR Ratio as Possible Predictor of Response in Phase I/II Study of Erlotinib and Bevacizumab for Recurrent or Metastatic Head and Neck Cancer
pKDR/KDR Ratio as Possible Predictor of Response in Phase I/II Study of Erlotinib and Bevacizumab for Recurrent or Metastatic Head and Neck Cancer
-
Download Poster Phase 1 Trial of a Combination of the VEGFR KinaseInhibitor Cediranib(AZD2171) and Bevacizumab in Advanced Malignancies
Phase 1 Trial of a Combination of the VEGFR KinaseInhibitor Cediranib(AZD2171) and Bevacizumab in Advanced Malignancies
%20and%20Bevacizumab%20in%20Advanced%20Malignancies.jpg?width=270&height=350&name=99.%20Phase%201%20Trial%20of%20a%20Combination%20of%20the%20VEGFR%20KinaseInhibitor%20Cediranib(AZD2171)%20and%20Bevacizumab%20in%20Advanced%20Malignancies.jpg)
